ZA201200366B - 3-cyanoquinoline tablet formulations and uses thereof - Google Patents
3-cyanoquinoline tablet formulations and uses thereofInfo
- Publication number
- ZA201200366B ZA201200366B ZA2012/00366A ZA201200366A ZA201200366B ZA 201200366 B ZA201200366 B ZA 201200366B ZA 2012/00366 A ZA2012/00366 A ZA 2012/00366A ZA 201200366 A ZA201200366 A ZA 201200366A ZA 201200366 B ZA201200366 B ZA 201200366B
- Authority
- ZA
- South Africa
- Prior art keywords
- cyanoquinoline
- tablet formulations
- formulations
- tablet
- cyanoquinoline tablet
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22253709P | 2009-07-02 | 2009-07-02 | |
PCT/US2010/040555 WO2011002857A2 (en) | 2009-07-02 | 2010-06-30 | 3-cyanoquinoline tablet formulations and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA201200366B true ZA201200366B (en) | 2012-10-31 |
Family
ID=42732381
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA2012/00366A ZA201200366B (en) | 2009-07-02 | 2012-01-17 | 3-cyanoquinoline tablet formulations and uses thereof |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP2448563A2 (zh) |
JP (1) | JP2011012063A (zh) |
KR (1) | KR20120046216A (zh) |
CN (1) | CN102470109A (zh) |
AR (1) | AR077546A1 (zh) |
AU (1) | AU2010266342A1 (zh) |
BR (1) | BRPI1015941A2 (zh) |
CA (1) | CA2766067A1 (zh) |
IL (1) | IL217298A0 (zh) |
MX (1) | MX2012000048A (zh) |
RU (1) | RU2011152105A (zh) |
SG (1) | SG177309A1 (zh) |
TW (1) | TW201113050A (zh) |
WO (1) | WO2011002857A2 (zh) |
ZA (1) | ZA201200366B (zh) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102886045A (zh) | 2005-02-03 | 2013-01-23 | 综合医院公司 | 治疗吉非替尼耐药性癌症的方法 |
EP1942937A1 (en) | 2005-11-04 | 2008-07-16 | Wyeth | Antineoplastic combinations with mtor inhibitor, herceptin, and/or hki-272 |
US8022216B2 (en) | 2007-10-17 | 2011-09-20 | Wyeth Llc | Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof |
PL2310011T3 (pl) | 2008-06-17 | 2013-12-31 | Wyeth Llc | Kombinacje przeciwnowotworowe zawierające HKI-272 i vinorelbine |
SG10202102855RA (en) | 2008-08-04 | 2021-05-28 | Wyeth Llc | Antineoplastic combinations of 4-anilino-3-cyanoquinolines and capecitabine |
MX356593B (es) | 2009-04-06 | 2018-06-05 | Wyeth Llc | Régimen de tratamiento que utiliza neratinib para cáncer de mama. |
PL2498756T5 (pl) * | 2009-11-09 | 2023-04-17 | Wyeth Llc | Preparaty maleinianu neratynibu w postaci tabletki |
CN107308130B (zh) | 2009-11-09 | 2021-06-15 | 惠氏有限责任公司 | 包衣药物球状体及消除或减少病症如呕吐和腹泻的用途 |
CN104447541A (zh) * | 2013-09-16 | 2015-03-25 | 天津市汉康医药生物技术有限公司 | 博舒替尼化合物 |
CN105384686B (zh) * | 2014-09-04 | 2019-07-26 | 连云港润众制药有限公司 | 一种博舒替尼结晶方法 |
WO2017175855A1 (en) * | 2016-04-08 | 2017-10-12 | Shionogi & Co., Ltd. | Stabilized solid dosage form |
JP7086938B2 (ja) | 2017-03-31 | 2022-06-20 | 日精エー・エス・ビー機械株式会社 | 樹脂製容器 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6297258B1 (en) | 1998-09-29 | 2001-10-02 | American Cyanamid Company | Substituted 3-cyanoquinolines |
UA76325C2 (uk) * | 2002-02-26 | 2006-07-17 | Астразенека Аб | Лікарський препарат іресси, який містить водорозчинне похідне целюлози (варіанти), та спосіб його одержання |
MXPA06001590A (es) | 2003-08-19 | 2006-05-19 | Wyeth Corp | Proceso para la preparacion de 4-amino-3-quinolincarbonitrilos. |
ATE428421T1 (de) * | 2004-09-17 | 2009-05-15 | Eisai R&D Man Co Ltd | Medizinische zusammensetzung mit verbesserter stabilität und reduzierten gelierungseigenschaften |
BRPI0613574A2 (pt) * | 2005-07-01 | 2016-11-16 | Wyeth Corp | forma cristalina isolada de um composto, método para preparar um composto, e, composição farmacêutica |
WO2008053295A2 (en) * | 2006-10-30 | 2008-05-08 | Wockhardt Research Centre | Pharmaceutical compositions of benzoquinolizine-2-carboxylic acid |
CN101224185A (zh) * | 2007-12-11 | 2008-07-23 | 山东蓝金生物工程有限公司 | 一种治疗实体肿瘤的伯舒替尼缓释植入剂 |
-
2010
- 2010-06-30 SG SG2011094950A patent/SG177309A1/en unknown
- 2010-06-30 CN CN2010800294791A patent/CN102470109A/zh active Pending
- 2010-06-30 RU RU2011152105/15A patent/RU2011152105A/ru unknown
- 2010-06-30 BR BRPI1015941A patent/BRPI1015941A2/pt not_active Application Discontinuation
- 2010-06-30 CA CA2766067A patent/CA2766067A1/en not_active Abandoned
- 2010-06-30 WO PCT/US2010/040555 patent/WO2011002857A2/en active Application Filing
- 2010-06-30 MX MX2012000048A patent/MX2012000048A/es not_active Application Discontinuation
- 2010-06-30 EP EP10732568A patent/EP2448563A2/en not_active Withdrawn
- 2010-06-30 KR KR1020127002851A patent/KR20120046216A/ko not_active Application Discontinuation
- 2010-06-30 AU AU2010266342A patent/AU2010266342A1/en not_active Abandoned
- 2010-07-01 JP JP2010151063A patent/JP2011012063A/ja not_active Withdrawn
- 2010-07-01 TW TW099121740A patent/TW201113050A/zh unknown
- 2010-07-02 AR ARP100102373A patent/AR077546A1/es not_active Application Discontinuation
-
2011
- 2011-12-29 IL IL217298A patent/IL217298A0/en unknown
-
2012
- 2012-01-17 ZA ZA2012/00366A patent/ZA201200366B/en unknown
Also Published As
Publication number | Publication date |
---|---|
SG177309A1 (en) | 2012-02-28 |
JP2011012063A (ja) | 2011-01-20 |
WO2011002857A2 (en) | 2011-01-06 |
KR20120046216A (ko) | 2012-05-09 |
BRPI1015941A2 (pt) | 2016-04-19 |
MX2012000048A (es) | 2012-01-27 |
CN102470109A (zh) | 2012-05-23 |
EP2448563A2 (en) | 2012-05-09 |
AR077546A1 (es) | 2011-09-07 |
TW201113050A (en) | 2011-04-16 |
RU2011152105A (ru) | 2013-08-10 |
WO2011002857A3 (en) | 2011-03-10 |
AU2010266342A1 (en) | 2012-01-19 |
CA2766067A1 (en) | 2011-01-06 |
IL217298A0 (en) | 2012-02-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20181755T1 (hr) | Formulacije tableta s trenutnim oslobađanjem | |
IL253870B (en) | Certain amino-pyrimidines and pharmaceutical preparations containing them | |
ZA201200366B (en) | 3-cyanoquinoline tablet formulations and uses thereof | |
EP2515946A4 (en) | NANOCONJUGATES AND COMPOSITIONS OF NANOCONJUGATES | |
IL214911A0 (en) | Solfonylated tetrahydroazolopyrazines and their use as medicinal products | |
ZA201200722B (en) | Pharmaceutical composition and administrations thereof | |
ZA201108697B (en) | Quinoline derivatives-containing pharmaceutical composition | |
HK1169960A1 (en) | Pharmaceutical formulation | |
PL2469142T3 (pl) | Złączka zaciskowa i jej zastosowanie | |
EP2474522A4 (en) | AGOMÉLATINE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | |
SI2605757T1 (sl) | Formulacije na osnovi nalbufina in njihove uporabe | |
ZA201106702B (en) | Sceletium extract and uses thereof | |
GB0921001D0 (en) | Products and uses | |
ZA201200761B (en) | Tablet | |
ZA201200079B (en) | Pharmaceutical compositions and solid forms | |
AU330360S (en) | Tablet | |
SG10201401678TA (en) | Tablet and pestle therefor | |
GB0920041D0 (en) | Tablet | |
GB0902648D0 (en) | Pharmaceutical compounds and compositions | |
PL2491021T3 (pl) | Nowe acylopiperazynony i ich zastosowanie jako środki farmaceutyczne | |
GB0908317D0 (en) | Pharmaceutical compounds and compositions | |
GB0906703D0 (en) | Excipients and their use | |
GB0903145D0 (en) | Medicaments uses and methods | |
AU331949S (en) | Tablet | |
AU330359S (en) | Tablet |